Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Intraepithelial Lesions 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Sarcoma, Kaposi 1Sarcoma 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Precancerous Conditions 1Pneumonia 1Papilloma 1Pain 1Neutropenia 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Intraabdominal Infections 1Influenza, Human 1Inflammation 1Infections 1Hypokalemia 1Hypertension 1

Interventions

green tea extract polyphenone E 1Ointments 1Electrocoagulation 1Cidofovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × High-grade Anal Intraepithelial Neoplasia × Cidofovir × Clear all
NCT04055142 2024-07-10

TreatAIN

Hospital Universitari Vall d'Hebron Research Institute

Phase 3 Completed
108 enrolled

High-grade Anal Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡